NKX3-1 and prostate carcinoma: The mouse models with CDKN1B disruption in combination with other genetic factors, such as Pten and Nkx3.1, have been shown to develop a range of prostate cancers, although CDKN1B inactivation alone displays no obvious neoplastic prostate lesions [19,25].